Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305.
Department of Molecular & Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305.
Proc Natl Acad Sci U S A. 2019 May 28;116(22):10819-10823. doi: 10.1073/pnas.1821513116. Epub 2019 May 14.
In the companion paper by Ufimtsev and Levitt [Ufimtsev IS, Levitt M (2019) , 10.1073/pnas.1821512116], we presented a method for unsupervised solution of protein crystal structures and demonstrated its utility by solving several test cases of known structure in the 2.9- to 3.45-Å resolution range. Here we apply this method to solve the crystal structure of a 966-amino acid construct of human lethal giant larvae protein (Lgl2) that resisted years of structure determination efforts, at 3.2-Å resolution. The structure was determined starting with a molecular replacement (MR) model identified by unsupervised refinement of a pool of 50 candidate MR models. This initial model had 2.8-Å RMSD from the solution. The solved structure was validated by comparison with a model subsequently derived from an alternative crystal form diffracting to higher resolution. This model could phase an anomalous difference Fourier map from an Hg derivative, and a single-wavelength anomalous dispersion phased density map made from these sites aligned with the refined structure.
在 Ufimtsev 和 Levitt 的相关论文中[Ufimtsev IS, Levitt M (2019), 10.1073/pnas.1821512116],我们提出了一种用于蛋白质晶体结构无监督求解的方法,并通过解决已知结构的几个测试案例(分辨率范围为 2.9 至 3.45 Å)证明了其有效性。在此,我们将该方法应用于解决人类致死巨幼虫蛋白(Lgl2)的 966 个氨基酸结构的晶体结构,分辨率为 3.2 Å。该结构是从通过对 50 个候选分子替换(MR)模型的无监督细化确定的 MR 模型开始确定的。该初始模型与从溶液中得出的解决方案的 RMSD 为 2.8 Å。通过与随后从更高分辨率的另一种晶体形式衍射得出的模型进行比较来验证解决的结构。该模型可以从 Hg 衍生物的异常差异傅立叶图中相位,并且从这些位置得出的单波长异常分散相密度图与精修结构对齐。